Latest news with #BloodStem
Yahoo
13-05-2025
- Business
- Yahoo
Cord Blood Stem Cells Global Market Overview 2025: Rising Demand for Regenerative Therapies, Technological Advances in Cryopreservation and Processing Boost Growth Prospects
This global report on Cord Blood Stem Cells analyzes the market based on technology, storage, and application for the period 2021-2030 with projections from 2024 to 2030 in terms of value in US$. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing. Cord Blood Stem Cells Market Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Cord Blood Stem Cells - A Global Market Overview" report has been added to global cord blood stem cells market is estimated to be valued at $54.8 billion in 2024 and is projected to grow to $80.4 billion by 2030, with a CAGR of 6.6% during the forecast period 2024-2030 The growth of the global cord blood stem cell market is driven by several key factors, including increased awareness of the therapeutic potential of cord blood stem cells and advancements in banking technologies. The rising incidence of cancer and blood-related diseases, such as leukemia, lymphoma, and genetic disorders, is boosting demand, along with the growing use of regenerative medicine applications. Government initiatives and supportive policies, combined with investments from both public and private sectors, are enhancing research, infrastructure, and accessibility to cord blood banking services. Technological advancements, such as improved cryopreservation methods and automation in processing, further contribute to market growth. Emerging markets present significant opportunities due to expanding healthcare infrastructure and heightened awareness of cord blood banking. Additionally, collaborations among research organizations, healthcare providers, and cord blood banks are fostering innovation and broadening the applications of cord blood stem Blood Stem Cells Regional Market AnalysisNorth America holds the largest share of the global cord blood stem cells market, accounting for 39.5% in 2024, due to a robust healthcare infrastructure, widespread adoption of advanced stem cell therapies, and the strong presence of leading cord blood banking companies. Additionally, substantial investment in research and development, coupled with increasing public awareness of the benefits of cord blood stem cells for treating various diseases, further drives the market. In contrast, the Asia-Pacific is the fastest-growing market, with a projected CAGR of 8.3% during the forecast period 2024-2030, fueled by government initiatives to promote cord blood banking, rising healthcare expenditure, and a growing population with increased awareness of stem cell applications. Countries like China, India, and Japan lead this expansion due to their developing healthcare systems and emphasis on regenerative Blood Stem Cells Market Analysis by TechnologyThe cord blood stem cells market is segmented by technology into stem cell transplant, cord blood banking, cell-based genetics, blood transfusion, and xenotransplant. Among these, the stem cell transplant segment holds the largest market, with an estimated 32.80% share in 2024. Stem cell transplants, especially for cancer and blood disorder treatments, are key applications of cord blood stem cells and significantly contribute to their market growth. Conversely, Cell-based genetics segment is projected to record the fastest growth with a CAGR of 8.6% from 2024 to 2030. This growth is driven by advancements in genetic treatments, including gene editing and therapies that utilize stem cells, which have demonstrated significant potential in addressing genetic disorders and various other conditions. The utilization of cell-based genetic technologies is quickly growing as innovations in CRISPR and other gene-editing methods present promising therapeutic Blood Banking Market Analysis by StorageIn the cord blood banking market, private storage dominates, with an estimated market share of 57.6% in 2024, influenced by an increasing preference among parents for tailored storage options and the potential future applications of cord blood for family use. Private banks draw families in by providing exclusive access to the stored units, which enhances their appeal even though the costs are expensive. On the other hand, public storage is projected to experience significant growth, with a CAGR of 7% during the forecast period 2024-2030. This growth is driven by increased awareness regarding the importance of donating cord blood for public use, its effectiveness in unrelated transplants, and its contribution to advancing stem cell research. Public banks play a crucial role in establishing accessible and diverse inventories for patients requiring transplants, particularly those who do not have matching Blood Stem Cells Market Analysis by ApplicationThe cord blood stem cells market is segmented by application into cancer, blood disorders, immune disorders, metabolic disorders, osteopetrosis, and other applications. Among these applications, cancer and blood disorders account for more than 60% of the market in 2024. These segments, particularly for hematologic cancers such as leukemia and lymphoma, as well as blood disorders like sickle cell anemia and thalassemia, are the most prominent and well-established applications of cord blood stem cells. The notable success rates observed in cord blood transplants for these diseases and the increasing number of patients enhance their market dominance. Cancer is anticipated to be the fastest-growing segment, with a CAGR of 7% from 2024 to 2030, driven by the increasing prevalence of cancer globally, particularly hematologic cancers, along with greater recognition of cord blood as a viable treatment option for patients without appropriate bone marrow donors. Innovations in transplant methodologies and the broadening clinical applications for cord blood in cancer care further drive this segment's Metrics Historical Period: 2021-2023 Base Year: 2024 Forecast Period: 2024-2030 Units: Value market in US$ Companies Mentioned: 30+ Key Attributes: Report Attribute Details No. of Pages 217 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $54.8 Billion Forecasted Market Value (USD) by 2030 $80.4 Billion Compound Annual Growth Rate 6.6% Regions Covered Global Key Global Players Alphacord LLC Americord Registry LLC Banco de Cordon Umbilical (BCU) Beike Biotechnology Co., Ltd. BIOCORD AG Carolinas Cord Blood Bank (CCBB) Cells4Life Group LLP CooperSurgical Inc. CordBank NZ Cordlife Group Limited Coriell Institute for Medical Research Cryo Stemcell Karnataka Pvt Ltd Cryo-Cell International, Inc. Cryosite Limited Cryoviva Biotech Pvt. Ltd. CytoMed Therapeutics Limited Famicord Group Future Health Biobank HUCORD (Hucord Co. Ltd) INNOVIA BioBank Jeevan Stem Cell Foundation LifeCell International Pvt. Ltd MEDIPOST Co. Ltd. Mesoblast Limited New England Cord Blood Bank, Inc. Regrow Biosciences Pvt Ltd Reliance Life Sciences Singapore Cord Blood Bank (SCBB) StemCell Institute Inc. STEMCELL Technologies Canada Inc. StemCyte Inc ViaCord (a part of Revvity) VITA 34 AG Global Market Overview Global Cord Blood Stem Cells Market Overview by Technology Cord Blood Stem Cells Technology Market Overview by Global Region Stem Cell Transplant Cord Blood Banking Global Cord Blood Banking Market Overview by Storage Cord Blood Banking Storage Market Overview by Global Region Private Public Blood Transfusion Cell-Based Genetics Xenotransplant Global Cord Blood Stem Cells Market Overview by Application Cord Blood Stem Cells Application Market Overview by Global Region Cancer Blood Disorders Immune Disorders Metabolic Disorders Osteopetrosis Other Applications (Including Cardiovascular Disorders, Neurological Disorders, and Others) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Cord Blood Stem Cells Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Jordan News
15-03-2025
- Health
- Jordan News
Blood Donation Offers Unexpected Health Benefits - Jordan News
A recent study has revealed that regular blood donation may provide health benefits that go beyond saving the lives of others. A team of scientists from the Francis Crick Institute conducted a study involving 217 men who donated blood more than 100 times, comparing them with 212 men who donated blood fewer than 10 times. اضافة اعلان The results showed that frequent blood donation is associated with mutations in the DNMT3A gene, which plays a key role in blood cell production. In laboratory experiments, the scientists sought to understand why this mutation is common among frequent blood donors. They exposed genetically modified human blood cells to the hormone erythropoietin (EPO), which helps regulate red blood cell production. They found that cells carrying the DNMT3A mutation grew 50% faster when exposed to this hormone compared to normal cells. Regular blood donation increases EPO levels in the body, which enhances the regeneration of stem cells and improves blood health. Dr. Dominique Bonne, head of the Blood Stem Cell Laboratory at the Crick Institute and the lead author of the study, stated: "Our study sheds light on how our genes interact with the environment and how we age. It seems that activities that reduce the stress on blood cell production enhance stem cell regeneration, supporting their healthy growth instead of causing disease." In another experiment, the scientists mixed cells with the DNMT3A mutation with cells exposed to leukemia, and found that cells from frequent blood donors grew at a faster rate. This suggests that regular donation may strengthen healthy cells and limit the growth of cancerous cells. However, the scientists emphasized the need for further studies to determine the exact effect of blood donation on cancer risk, particularly as blood donors are typically healthy individuals, which may affect the results. Bonne clarified, "Our sample size is relatively small, so we cannot conclusively say that blood donation reduces mutations linked to leukemia. However, this study provides valuable information about how certain mutations impact blood cell health." In addition to its potential role in cancer prevention, regular blood donation may also help lower blood pressure. A study involving 292 blood donors found that individuals with high blood pressure saw improvements in their readings after regular donations, with more noticeable improvements the more often they donated. (Original Source: The Sun)
